<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated">
      <PMID Version="1">30677308</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1553-4014</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <PubDate>
              <Year>2019</Year>
              <Month>Jan</Month>
              <Day>24</Day>
            </PubDate>
          </JournalIssue>
          <Title>Annual review of pathology</Title>
          <ISOAbbreviation>Annu Rev Pathol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Malformations of Cerebral Cortex Development: Molecules and Mechanisms.</ArticleTitle>
        <Pagination>
          <StartPage>293</StartPage>
          <EndPage>318</EndPage>
          <MedlinePgn>293-318</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1146/annurev-pathmechdis-012418-012927</ELocationID>
        <Abstract>
          <AbstractText>Malformations of cortical development encompass heterogeneous groups of structural brain anomalies associated with complex neurodevelopmental disorders and diverse genetic and nongenetic etiologies. Recent progress in understanding the genetic basis of brain malformations has been driven by extraordinary advances in DNA sequencing technologies. For example, somatic mosaic mutations that activate mammalian target of rapamycin signaling in cortical progenitor cells during development are now recognized as the cause of hemimegalencephaly and some types of focal cortical dysplasia. In addition, research on brain development has begun to reveal the cellular and molecular bases of cortical gyrification and axon pathway formation, providing better understanding of disorders involving these processes. New neuroimaging techniques with improved resolution have enhanced our ability to characterize subtle malformations, such as those associated with intellectual disability and autism. In this review, we broadly discuss cortical malformations and focus on several for which genetic etiologies have elucidated pathogenesis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Juric-Sekhar</LastName>
            <ForeName>Gordana</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98195, USA; email: gordana@uw.edu , rhevner@ucsd.edu.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Surgery, University of Washington School of Medicine, Seattle, Washington 98195, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hevner</LastName>
            <ForeName>Robert F</ForeName>
            <Initials>RF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, University of Washington School of Medicine, Seattle, Washington 98195, USA; email: gordana@uw.edu , rhevner@ucsd.edu.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurological Surgery, University of Washington School of Medicine, Seattle, Washington 98195, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, Washington 98105, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Current affiliation: Department of Pathology, University of California, San Diego, California 92093, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 NS085081</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 NS092339</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Annu Rev Pathol</MedlineTA>
        <NlmUniqueID>101275111</NlmUniqueID>
        <ISSNLinking>1553-4006</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName>
          <QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065705" MajorTopicYN="N">Hemimegalencephaly</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008607" MajorTopicYN="N">Intellectual Disability</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054082" MajorTopicYN="N">Lissencephaly</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054220" MajorTopicYN="N">Malformations of Cortical Development</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008831" MajorTopicYN="N">Microcephaly</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065886" MajorTopicYN="N">Neurodevelopmental Disorders</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D065706" MajorTopicYN="N">Polymicrogyria</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">focal cortical dysplasia</Keyword>
        <Keyword MajorTopicYN="Y">hemimegalencephaly</Keyword>
        <Keyword MajorTopicYN="Y">hippocampal dysgenesis</Keyword>
        <Keyword MajorTopicYN="Y">lissencephaly</Keyword>
        <Keyword MajorTopicYN="Y">microcephaly</Keyword>
        <Keyword MajorTopicYN="Y">polymicrogyria</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>1</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>1</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30677308</ArticleId>
        <ArticleId IdType="mid">NIHMS1064843</ArticleId>
        <ArticleId IdType="pmc">PMC6938687</ArticleId>
        <ArticleId IdType="doi">10.1146/annurev-pathmechdis-012418-012927</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Bystron I, Blakemore C, Rakic P. 2008. 
Development of the human cerebral cortex: Boulder Committee revisited. Nat Rev Neurosci
9:110–132</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18209730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB. 2012. 
A developmental and genetic classification for malformations of cortical development: update 2012. Brain
135:1348–1369</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3338922</ArticleId>
            <ArticleId IdType="pubmed">22427329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerrini R, Dobyns W. 2014. 
Malformations of cortical development: clinical features and genetic causes. Lancet Neurology
13:710–726</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5548104</ArticleId>
            <ArticleId IdType="pubmed">24932993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuzniecky RI. 1994. 
Magnetic resonance imaging in developmental disorders of the cerebral cortex. Epilepsia
35
Suppl 6:S44–56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8206014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leventer RJ, Phelan EM, Coleman LT, et al.
1999. 
Clinical and imaging features of cortical malformations in childhood. Neurology
53:715–722</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10489031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barkovich AJ, Dobyns WB, Guerrini R. 2015. 
Malformations of cortical development and epilepsy. Cold Spring Harb Perspect Med
5:a022392.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4448581</ArticleId>
            <ArticleId IdType="pubmed">25934463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jamuar SS, Lam AT, Kircher M, D’Gama AM, Wang J, et al.
2014. 
Somatic mutations in cerebral cortical malformations. N Engl J Med
371:733–43</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4274952</ArticleId>
            <ArticleId IdType="pubmed">25140959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li J, Cai T, Jiang Y, Chen H, He X, et al.
2016. 
Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database. Mol Psychiatry
21:290–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4837654</ArticleId>
            <ArticleId IdType="pubmed">25849321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilfert AB, Sulovari A, Turner TN, Coe BP, Eichler EE. 2017. 
Recurrent de novo mutations in neurodevelopmental disorders: properties and clinical implications. Genome Med
9:101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5704398</ArticleId>
            <ArticleId IdType="pubmed">29179772</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lombroso CT. 2000. 
Can early postnatal closed head injury induce cortical dysplasia. Epilepsia. 41:245–253</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10691125</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sarnat HB. 1987. 
Disturbance of late neuronal migrations in the perinatal period. Am J Dis Child
141:969–980</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2441596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hong SJ, Bernhardt BC, Gill RS, Bernasconi N, Bernasconi A. 2017. 
The spectrum of structural and functional network alterations in malformations of cortical development. Brain
140:2133–2143</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28899007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Happle R
1997. 
A rule concerning the segmental manifestation of autosomal dominant skin disorders. Review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol
133:1505–9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9420534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jansen LA, Mirzaa GM, Ishak GE, O’Roak BJ, Hiatt JB, et al.
2015. 
PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain
138:1613–28</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4614119</ArticleId>
            <ArticleId IdType="pubmed">25722288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qin W, Chan JA, Vinters HV, Mathern GW, Franz DN, et al.
2010. 
Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events. Brain Pathol
20:1096–105</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2951479</ArticleId>
            <ArticleId IdType="pubmed">20633017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mallinger G, Kindron D, Schreiber L, Ben-Sira L, Hoffman C, et al.
2007. 
Prenatal diagnosis of malformations of cortical development by dedicated neurosonography. Ultrasound Obstet Gynecol
29:178–91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17219377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barkovich AJ, Kuzniecky RI, Dobyns WB, Jackson GD, Becker LE, et al.
1996. 
A classification scheme for malformations of cortical development. Neuropediatrics
27:59–63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8737819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Desikan RS, Barkovich AJ. 2016. 
Malformations of cortical development . Ann Neurol
80:797–810</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5177533</ArticleId>
            <ArticleId IdType="pubmed">27862206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Romero DM, Bahi-Buisson N, Francis F. 2017. 
Genetics and mechanisms leading to human cortical malformations. Semin Cell Dev Biol [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28951247</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thornton GK, Woods CG. 2009. 
Primary microcephaly: do all roads lead to Rome?
Trends Genet
25:501–10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2816178</ArticleId>
            <ArticleId IdType="pubmed">19850369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu TW, Mochida GH, Tischfield DJ, Sgaier SK, Flores-Sarnat L, et al.
2010. 
Mutations in WDR62, encoding a centrosome-associated protein, cause microcephaly with simplified gyri and abnormal cortical architecture. Nat Gen
42:1015–20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2969850</ArticleId>
            <ArticleId IdType="pubmed">20890278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bahi-Buisson N, Poirier K, Fourniol F, Saillaour Y, Valence S, et al.
2014. 
The wide spectrum of tubulinopathies: what are the key features for the diagnosis?
Brain
137:1676–1700</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24860126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Donato N, Chiari S, Mirzaa GM, Aldinger K, Parrini E, et al.
2017. 
Lissencephaly: expanded imaging and clinical classification. Am J Med Genet
173A:1473–88</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5526446</ArticleId>
            <ArticleId IdType="pubmed">28440899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bahi-Buisson N, Poirier N, Boddaert N, Fallet-Bianco C, Specchio N, et al.
2010. 
GPR56-related bilaeral frontoparietal polymicrogyria: further evidence for an overlap with the cobblestone complex. Brain
133:3194–209</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20929962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rivas L, Blanco O, Torreira C, Repáraz A, Melcón C, Amado A. 2017. 
Pontocerebellar hypoplasia secondary to CASK gene deletion. Case report. Rev Chil Pediatr
88:529–33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28898323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rakic P
1988. 
Specification of cerebral cortical areas. Science
241:170–6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3291116</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Welker W
1990. 
Why does cerebral cortex fissure and fold? A review of determinants of gyri and sulci in cerebral cortex. In: Cerebral Cortex, Vol 8B (eds. Jones EG &amp; Peters A) Springer, 1990.</Citation>
        </Reference>
        <Reference>
          <Citation>Anderson SA, Eisenstat DD, Shi L, Rubenstein JL. 1997. 
Interneuron migration from basal forebrain to neocortex: dependence on Dlx genes. Science
278:474–6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9334308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chu J, Anderson SA. 2015. 
Development of cortical interneurons. Neuropsychopharmacology
40:16–23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4262895</ArticleId>
            <ArticleId IdType="pubmed">25103177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lui JH, Hansen DV, Kriegstein AR. 2011. 
Development and evolution of the human neocortex. Cell
146:18–36</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3610574</ArticleId>
            <ArticleId IdType="pubmed">21729779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun T, Hevner RF. 2014. 
Growth and folding of the mammalian cerebral cortex: from molecules to malformations. Nat Rev Neurosci
15:217–32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4107216</ArticleId>
            <ArticleId IdType="pubmed">24646670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kowalczyk T, Pontious A, Englund C, Daza RA, Bedogni F, et al.
2009. 
Intermediate neuronal progenitors (basal progenitors) produce pyramidal-projection neurons for all layers of cerebral cortex. Cereb Cortex
19:2439–50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2742596</ArticleId>
            <ArticleId IdType="pubmed">19168665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kriegstein A, Noctor S, Martínez-Cerdeño V. 2006. 
Patterns of neural stem and progenitor cell division may underlie evolutionary cortical expansion. Nat Rev Neurosci
7:883–90</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17033683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hevner RF. 2016. 
Evolution of the mammalian dentate gyrus. J Comp Neurol
524:578–94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4706817</ArticleId>
            <ArticleId IdType="pubmed">26179319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smart IH, Dehay C, Giroud P, Berland M, Kennedy H. 2002. 
Unique morphological features of the proliferative zones and postmitotic compartments of the neural epithelium giving rise to striate and extrastriate cortex in the monkey. Cereb Cortex
12:37–53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1931430</ArticleId>
            <ArticleId IdType="pubmed">11734531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hansen DV, Lui JH, Parker PR, Kriegstein AR. 2010. 
Neurogenic radial glia in the outer subventricular zone of human neocortex. Nature
464:554–61</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20154730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nowakowski TJ, Bhaduri A, Pollen AA, Alvarado B, Mostajo-Radji MA, et al.
2017. 
Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortex. Science
358:1318–23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5991609</ArticleId>
            <ArticleId IdType="pubmed">29217575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nowakowski TJ, Pollen AA, Sandoval-Espinosa C, Kriegstein AR. 2016. 
Transformation of the radial glia scaffold demarcates two stages of human cerebral cortex development. Neuron
91:1219–27</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5087333</ArticleId>
            <ArticleId IdType="pubmed">27657449</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Juan Romero C, Bruder C2, Tomasello U1, Sanz-Anquela JM3, Borrell V
2015. 
Discrete domains of gene expression in germinal layers distinguish the development of gyrencephaly. EMBO J
34:1859–74</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4547892</ArticleId>
            <ArticleId IdType="pubmed">25916825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsumoto N, Shinmyo Y, Ichikawa Y, Kawasaki H. 2017. 
Gyrification of the cerebral cortex requires FGF signaling in the mammalian brain. Elife
14;6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5685484</ArticleId>
            <ArticleId IdType="pubmed">29132503</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malik S, Vinukonda G, Vose LR, Diamond D, Bhimavarapu BB, et al.
2013. 
Neurogenesis continues in the third trimester of pregnancy and is suppressed by premature birth. J Neurosci
33:411–23</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3711635</ArticleId>
            <ArticleId IdType="pubmed">23303921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sorrells SF, Paredes MF, Cebrian-Silla A, Sandoval K, Qi D, et al.
2018. 
Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6179355</ArticleId>
            <ArticleId IdType="pubmed">29513649</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greig LC, Woodworth MB, Galazo MJ, Padmanabhan H, Macklis JD. 2013. 
Molecular logic of neocortical projection neuron specification, development and diversity. Nat Rev Neurosci
14:755–69</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3876965</ArticleId>
            <ArticleId IdType="pubmed">24105342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bedogni F, Hodge RD, Elsen GE, Nelson BR, Daza RA, et al.
2010. 
Tbr1 regulates regional and laminar identity of postmitotic neurons in developing neocortex. Proc Natl Acad Sci USA
107:13129–34</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2919950</ArticleId>
            <ArticleId IdType="pubmed">20615956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hevner RF. 2005. 
The cerebral cortex malformation in thanatophoric dysplasia: neuropathology and pathogenesis. Acta Neuropathol
110:208–21</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16133544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blümcke I, Thom M, Aronica E, Armstrong DD, Vinters HV, et al.
2011. 
The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia
52:158–74</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3058866</ArticleId>
            <ArticleId IdType="pubmed">21219302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blümcke I, Spreafico R, Haaker G, Coras R, Kobow K, et al.
2017. 
Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med
377:1648–56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29069555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vanhaesebroeck B, Stephens L, Hawkins P. 2012. 
PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol
13:195–203</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22358332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saxton RA, Sabatini DM. 2017. 
mTOR signaling in growth, metabolism, and disease. Cell
168:960–76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5394987</ArticleId>
            <ArticleId IdType="pubmed">28283069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janku F, Yap TA, Meric-Bernstam F. 2018. 
Targeting the PI3K pathway in cancer: are we making headway?
Nat Rev Clin Oncol [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29508857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iwata T, Hevner RF. 2009. 
Fibroblast growth factor signalling in development of the cerebral cortex. Dev Growth Differ
51:299–323</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19379279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kunova Bosakova M, Varecha M, Hampl M, Duran I, et al.
2018. 
Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies. Hum Mol Genet [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5886260</ArticleId>
            <ArticleId IdType="pubmed">29360984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Puffenberger EG, Strauss KA, Ramsey KE, Craig DW, Stephan DA, et al.
2007. 
Polyhydramnios, megalencephaly and symptomatic epilepsy caused by a homozygous 7-kilobase deletion in LYK5. Brain
130:1929–41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17522105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindhurst MJ, Sapp JC, Teer JK, Johnston JJ, Finn EM, et al.
2011. 
A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med
365:611–9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3170413</ArticleId>
            <ArticleId IdType="pubmed">21793738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee JH, Huynh M, Silhavy JL, Kim S, Dixon-Salazar T, et al.
2012. 
De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet
44:941–5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4417942</ArticleId>
            <ArticleId IdType="pubmed">22729223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poduri A, Evrony GD, Cai X, Elhosary PC, Beroukhim R, et al.
2012. 
Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron
74:41–8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3460551</ArticleId>
            <ArticleId IdType="pubmed">22500628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rivière JB, Mirzaa GM, O’Roak BJ, Beddaoui M, Alcantara D, et al.
2012. 
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet
44:934–40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3408813</ArticleId>
            <ArticleId IdType="pubmed">22729224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Borrie SC, Brems H, Legius E, Bagni C. 2017. 
Cognitive dysfunctions in intellectual disabilities: the contributions of the Ras-MAPK and PI3K-AKT-mTOR pathways. Annu Rev Genomics Hum Genet
18:115–42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28859574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reijnders MRF, Kousi M, van Woerden GM, Klein M, Bralten J, et al.
2017. 
Variation in a range of mTOR-related genes associates with intracranial volume and intellectual disability. Nat Commun
8:1052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5648772</ArticleId>
            <ArticleId IdType="pubmed">29051493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yeung KS, Tso WWY, Ip JJK, Mak CCY, Leung GKC, et al.
2017. 
Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism. Mol Autism [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5738835</ArticleId>
            <ArticleId IdType="pubmed">29296277</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alcantara D, Timms AE, Gripp K, Baker L, Park K, et al.
2017. 
Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly. Brain
140:2610–22</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6080423</ArticleId>
            <ArticleId IdType="pubmed">28969385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>D’Gama AM, Woodworth MB, Hossain AA, Bizzotto S, Hatem NE, et al.
2017. 
Somatic mutations activating the mTOR Pathway in dorsal telencephalic progenitors cause a continuum of cortical dysplasia. Cell Rep
21:3754–66</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5752134</ArticleId>
            <ArticleId IdType="pubmed">29281825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baek ST, Copeland B, Yun EJ, Kwon SK, Guemez-Gamboa A, et al.
2015. 
AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development. Nat Med
21:1445–54</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4955611</ArticleId>
            <ArticleId IdType="pubmed">26523971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conti V, Pantaleo M, Barba C1, Baroni G, Mei D, et al.
2015. 
Focal dysplasia of the cerebral cortex and infantile spasms associated with somatic 1q21.1-q44 duplication including the AKT3 gene. Clin Genet
88:241–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25091978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milone R, Valetto A, Battini R, Bertini V, Valvo G, et al.
2016. 
Focal cortical dysplasia, microcephaly and epilepsy in a boy with 1q21.1-q21.3 duplication. Eur J Med Genet
59:278–82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26975584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baulac S, Ishida S, Marsan E, Miquel C, Biraben A, et al.
2015. 
Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations. Ann Neurol
77:675–83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25623524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weckhuysen S, Marsan E, Lambrecq V, Marchal C, Morin-Brureau M, et al.
2016. 
Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia. Epilepsia
57:994–1003</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27173016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jansen LA, Hevner RF, Roden WH, Hahn SH, Jung S, Gospe SM Jr. 2014. 
Glial localization of antiquitin: implications for pyridoxine-dependent epilepsy. Ann Neurol
75:22–32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3945410</ArticleId>
            <ArticleId IdType="pubmed">24122892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uddin M, Woodbury-Smith M, Chan A, Brunga L, Lamoureux S, et al.
2017. 
Germline and somatic mutations in STXBP1 with diverse neurodevelopmental phenotypes. Neurol Genet
3(6):e199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5735305</ArticleId>
            <ArticleId IdType="pubmed">29264391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Kusky J, Ye P. 2012. 
Neurodevelopmental effects of insulin-like growth factor signaling. Front Neuroendocrinol
33:230–51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3677055</ArticleId>
            <ArticleId IdType="pubmed">22710100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Najm IM, Sarnat HB, Blümcke I. 2018. 
Review: The international consensus classification of Focal Cortical Dysplasia - a critical update 2018. Neuropathol Appl Neurobiol
44:18–31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29359399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flores-Sarnat L, Sarnat HB, Dávila-Gutiérrez G, Alvarez A. 2003. 
Hemimegalencephaly: part 2. Neuropathology suggests a disorder of cellular lineage. J Child Neurol
18:776–85</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14696906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Englund C, Folkerth RD, Born D, Lacy JM, Hevner RF. 2005. 
Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B). Acta Neuropathol
109:519–33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15877232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lamparello P, Baybis M, Pollard J, Hol EM, Eisenstat DD, et al.
2007. 
Developmental lineage of cell types in cortical dysplasia with balloon cells. Brain
130:2267–76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17711980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orlova KA, Tsai V, Baybis M, Heuer GG, Sisodiya S, et al.
2010. 
Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias. J Neuropathol Exp Neurol
69:850–63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3474261</ArticleId>
            <ArticleId IdType="pubmed">20613634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salamon N, Andres M, Chute DJ, Nguyen ST, Chang JW, et al.
2006. 
Contralateral hemimicrencephaly and clinical-pathological correlations in children with hemimegalencephaly. Brain
129:352–65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16291806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsai V, Parker WE, Orlova KA, Baybis M, Chi AW, et al.
2014. 
Fetal brain mTOR signaling activation in tuberous sclerosis complex. Cereb Cortex
24:315–27</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3888364</ArticleId>
            <ArticleId IdType="pubmed">23081885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boer K, Crino PB, Gorter JA, Nellist M, Jansen FE, et al.
2010. 
Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol
20:704–19</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2888867</ArticleId>
            <ArticleId IdType="pubmed">19912235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mühlebner A, van Scheppingen J, Hulshof HM, Scholl T, Iyer AM, et al.
2016. 
Novel histopathological patterns in cortical tubers of epilepsy surgery patients with tuberous sclerosis complex. PLoS One
11(6):e0157396.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4905625</ArticleId>
            <ArticleId IdType="pubmed">27295297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prabowo AS, Anink JJ, Lammens M, Nellist M, van den Ouweland AM, et al.
2013. 
Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain Pathol
23:45–59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3518755</ArticleId>
            <ArticleId IdType="pubmed">22805177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor DC, Falconer MA, Bruton CJ, Corsellis JA. 1971. 
Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry
34:369–87</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC493805</ArticleId>
            <ArticleId IdType="pubmed">5096551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krueger DA, Care MM, Holland K, Agricola K, Tudor C, et al.
2011. 
Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med
363:1801–11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21047224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, et al.
2014. 
Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study. Lancet Oncol
15:1513–20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25456370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parrini E, Conti V, Dobyns WB, Guerrini R. 2016. 
Genetic basis of brain malformations. Mol Syndromol
7:220–33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5073505</ArticleId>
            <ArticleId IdType="pubmed">27781032</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guerrini R, Filippi T. 2005. 
Neuronal migration disorders, genetics, and epileptogenesis. J Child Neurol
20:287–99</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15921228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leventer RJ, Guerrini R, Dobyns WB. 2008. 
Malformations of cortical development and epilepsy. Dialogues Clin Neurosci
10:47–62</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3181860</ArticleId>
            <ArticleId IdType="pubmed">18472484</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Forman MS, Squier W, Dobyns WB, Golden JA. 2005. 
Genotypically defined lissencephalies show distinct pathologies. J Neuropathol Exp Neurol
64:847–57</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16215456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reiner O, Carrozzo R, Shen Y, Wehnert M, Faustinella F, et al.
1993. 
Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature
364:717–721.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8355785</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cardoso C, Leventer RJ, Ward HL, Toyo-Oka K, Chung J, et al.
2003. 
Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3. Am J Hum Genet
72:918–30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1180354</ArticleId>
            <ArticleId IdType="pubmed">12621583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reiner O1, Sapir T. 2013. 
LIS1 functions in normal development and disease. Curr Opin Neurobiol
23:951–6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23973156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sicca F, Kelemen A, Genton P, Das S, Mei D, et al.
2003. 
Mosaic mutations of the LIS1 gene cause subcortical band heterotopia. Neurology
61:1042–6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14581661</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirotsune S, Fleck MW, Gambello MJ, Bix GJ, Chen A, et al.
1998. 
Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality. Nat Genet
19:333–9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9697693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keays DA, Tian G, Poirier K, Huang GJ, Siebold C, et al.
2007. 
Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell
128:45–57</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1885944</ArticleId>
            <ArticleId IdType="pubmed">17218254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fallet-Bianco C, Loeuillet L, Poirier K, Loget P, Chapon F, et al.
2008. 
Neuropathological phenotype of a distinct form of lissencephaly associated with mutations in TUBA1A. Brain
131:2304–20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18669490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poirier K, Lebrun N, Broix L, Tian G, Saillour Y, et al.
2013. 
Mutations in TUBG1, DYNC1H1, KIF5C and KIF2A cause malformations of cortical development and microcephaly. Nat Genet
45:639–67</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3826256</ArticleId>
            <ArticleId IdType="pubmed">23603762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colasante G, Collombat P, Raimondi V, Bonanomi D, Ferrai C, et al.
2008. 
Arx is a direct target of Dix2 and thereby contributes to the tangential migration of GABAergic interneurons. J Neurosci
28:10674–86</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3844830</ArticleId>
            <ArticleId IdType="pubmed">18923043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simonet JC, Sunnen CN, Wu J, Golden JA, Marsh ED. 2015. 
Conditional loss of Arx from the developing dorsal telencephalon results in behavioral phenotypes resembling mild human ARX mutations. Cereb Cortex
25:2939–50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4537438</ArticleId>
            <ArticleId IdType="pubmed">24794919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ventruti A, Kazdoba TM, Niu S, D’Arcangelo G. 2011. 
Reelin deficiency causes specific defects in the molecular composition of the synapses in the adult brain. Neuroscience
189:32–42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21664258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang BS. 2015. 
Tubulinopathies and their brain malformation syndromes: every TUB on its own bottom. Epilepsy Currents
15:65–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4519017</ArticleId>
            <ArticleId IdType="pubmed">26251641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harding BN, Moccia A, Drunat S, Soukarieh O, Tubeuf H, et al.
2016. 
Mutations in citron kinase cause recessive microlissencephaly with multinucleated neurons. Am J Human Genet
99:511–20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4974106</ArticleId>
            <ArticleId IdType="pubmed">27453579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Juric-Sekhar G, Kapur RP, Glass IA, Murray ML, Parnell SE, Hevner RF. 2011. 
Neuronal migration of disorders in microcephalic osteodysplastic primordial dwarfism type I/III. Acta Neuropathol
121:545–54</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3059390</ArticleId>
            <ArticleId IdType="pubmed">20857301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Wu X, Du L, Zheng J, Deng S, et al.
2018. 
Identification of compound heterozygous variants in the noncoding RNU4ATAC gene in a Chinese family with two successive foetuses with severe microcephaly. Hum Genomics
12:3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5784706</ArticleId>
            <ArticleId IdType="pubmed">29370840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dobyns WB, Kirkpatrick JB, Hittner HM, Roberts RM, Kretzer FL. 1985. 
Syndromes with lissencephaly. II: Walker-Warburg and cerebro-oculo-muscular syndromes and a new syndrome with type II lissencephaly. Am J Med Genet
22:157–95</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3931474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verrotti A, Spalice A, Ursitti F, Papetti, Mariani R, et al.
2010. 
New trends in neuronal migration disorders. Eur J Paediatr Neurol
14:1–12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19264520</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishigaki K, Ihara C, Mori-Yashimura M, Murakami T, Sato T, et al.
2016. 
Japanese nationwide registry for Fukuyama congenital muscular dystrophy patients. Neuromuscul Disord
26:suppl2
S164 [Abstract]</Citation>
        </Reference>
        <Reference>
          <Citation>Kobayashi K, Kato R, Kondo-Iida E, Taniguchi-Ikeda M, Osawa M, et al.
2017. 
Deep-intronic variant of fukutin in the most prevalent point mutation of Fukuyama congenital muscular dystrophy in Japan. J Hum Genet
62:945–48</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28680109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Devisme L, Bouchet C, Gonzalés M, Alanio E, Bazin A, et al.
2012. 
Cobblestone lissencephaly: Neuropathological subtypes and correlations with genes of dystroglycanopathies. Brain
135:469–82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22323514</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vuillaumier-Barrot S, Bouchet-Séraphin C, Chelbi M, Devisme L, Quentin S, et al.
2012. 
Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly. Am J Hum Genet
91:1135–43</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3516603</ArticleId>
            <ArticleId IdType="pubmed">23217329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Myshrall TD, Moore SA, Ostendorf AP, Satz JS, Kowalczyk T, et al.
2012. 
Dystroglycan on radial glia end feet is required for pial basement membrane integrity and columnar organization of the developing cerebral cortex. J Neuropath Exp Neurol
71:1047–63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3512206</ArticleId>
            <ArticleId IdType="pubmed">23147502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radmanesh F, Caglayan AO, Silhavy JL, Yilmaz C, Cantagrel V, et al.
2013. 
Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. Am J Hum Genet
92:468–74</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3591846</ArticleId>
            <ArticleId IdType="pubmed">23472759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Radner S, Banos C, Bachay G, Li YN, Hunter DD, et al.
2013. 
β2 and γ3 laminins are critical cortical basement membrane components: ablation of Lamb2 and Lamc3 genes disrupts cortical lamination and produces dysplasia. Dev Neurobiol
73:209–29</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22961762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bahi-Buisson N, Nectoux J, Girard B, Van Esch H, De Ravel T, et al.
2010. 
Revisiting the phenotype associated with FOXG1 mutations: two novel cases of congenital Rett variant. Neurogenetics
11:241–49</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19806373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Duerinckx S, Abramowicz M. 2017. 
The genetics of congenitally small brains. Semin Cell Dev Biol [Epub ahead of print]</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28912110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boland E, Clayton-Smith J, Woo VG, McKee S, Manson FD, et al.
2007. 
Mapping of deletion and translocation breakpoints in 1q44 implicates the serine/threonine kinase AKT3 in postnatal microcephaly and agenesis of the corpus callosum. Am J Hum Genet
81:292–303</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1950798</ArticleId>
            <ArticleId IdType="pubmed">17668379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shiba N, Daza RA, Shaffer LG, Barkovich AJ, Dobyns WB, Hevner RF. 2013. 
Neuropathology of brain and spinal malformations in a case of monosomy 1p36. Acta Neuropathol Commun
1:45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3893467</ArticleId>
            <ArticleId IdType="pubmed">24252393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Judkins AR, Martinez D, Ferreira P, Dobyns WB, Golden JA. 2011. 
Polymicrogyria includes fusion of the molecular layer and decreased neuronal populations but normal cortical laminar organization. J Neuropathol Exp Neurol
70:438–43</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3113653</ArticleId>
            <ArticleId IdType="pubmed">21572338</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jansen AC, Robitaille Y, Honavar M, Mullatti N, Leventer RJ, et al.
2016. 
The histopathology of polymicrogyria: a series of 71 brain autopsy studies. Dev Med Child Neurol
58:39–48</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26179148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edwards TJ, Sherr EH, Barkovich AJ, Richards LJ. 2014. 
Clinical, genetic and imaging findings identify new causes for corpus callosum development syndromes. Brain
137:1579–613</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4032094</ArticleId>
            <ArticleId IdType="pubmed">24477430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sotiriadis A, Makrydimas G. 2012. 
Neurodevelopment after prenatal diagnosis of isolated agenesis of the corpus callosum: an integrative review. Am J Obstet Gynecol
206:e331–e335</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22284958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hevner RF, Shi L, Justice N, Hsueh Y, Sheng M, et al.
2001. 
Tbr1 regulates differentiation of the preplate and layer 6. Neuron
29:353–66</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11239428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Donahoo AL, Richards LJ. 2009. 
Understanding of callosal development through the use of transgenic mouse modes. Semin Pediatr Neurol
16:127–42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19778710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chinn GA, Hirokawa KE, Chuang TM, Urbina C, Patel F, et al.
2015. 
Agenesis of the corpus callosum due to defective glial wedge formation in Lhx2 mutant mice. Cereb Cortex
25:2707–18</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4537429</ArticleId>
            <ArticleId IdType="pubmed">24781987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Driscoll MC, Black GC, Clayton-Smith J, Sherr EH, Dobyns WB. 2010. 
Identification of genomic loci contributing to agenesis of the corpus callosum. Am J Med Genet A
152A:2145–59</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20683985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Badano JL, Mitsuma, Beales PL, Katsanis N. 2006. 
The ciliopathies: an emerging class of the human genetic disorders. Annu Rev Genomics Hum Genet
7:125–48</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16722803</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alby C, Boutaud L, Bonniére M, Collardeau-Frachon S, Guibaud L, et al.
2018. 
In utero ultrasound diagnosis of corpus callosum agenesis leading to the identification of orofaciodigital type 1 syndrome in female fetuses. Birth Defects Res
110:382–389</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29193896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jouan L, Bencheikh BOA, Daoud H, Dionne-Laporte A, Dobrzeniecka S, et al.
2016. 
Exome sequencing identified recessive CDK5RAP2 variants in patients with isolated agenesis of corpus callosum. Eur J Hum Genet
24:607–10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4929875</ArticleId>
            <ArticleId IdType="pubmed">26197979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee JH, Huynh M, Silhavy JL, Kim S, Dixon-Salazar T, et al.
2012. 
De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet
44:941–5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4417942</ArticleId>
            <ArticleId IdType="pubmed">22729223</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirzaa G, Parry DA, Fry AE, Giamanco KA, Schwartzentruber J, et al.
2014. 
De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome. Nat Genet
46:510–515</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4004933</ArticleId>
            <ArticleId IdType="pubmed">24705253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>D’Gama AM, Geng Y, Couto JA, Martin B, Boyle EA, et al.
2015. 
Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia. Ann Neurol
77:720–5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4471336</ArticleId>
            <ArticleId IdType="pubmed">25599672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheffer IE, Heron SE, Regan BM, Mandelstam S, Crompton DE, et al.
2014. 
Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol
75:782–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24585383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scerri T, Riseley JR, Gillies G, Pope K, Burgess R, et al.
2015. 
Familiar cortical dysplasia type IIA caused by a germline mutation in DEPDC5. Ann Clin Transl Neurol
2:575–80</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4435711</ArticleId>
            <ArticleId IdType="pubmed">26000329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cen Z, Guo Y, Lou Y, Jiang B, Wang J, Feng J. 2017. 
De novo mutation in DEPDC5 associated with unilateral pachygyria and intractable epilepsy. Seizure
50:1–3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28549235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ricos MG, Hodgson BL, Pippucci T, Saidin A, Ong YS, et al.
2016. 
Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy. Ann Neurol
79:120–31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26505888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim JS, Kim WI, Kang HC, Kim SH, et al.
2015. 
Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med
21:395–400</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25799227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakashima M, Saitsu H, Takei N, Tohyama J, Kato M, et al.
2015. 
Somatic mutations in the MTOR gene cause focal cortical dysplasia type IIb. Ann Neurol
78:375–86</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26018084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leventer RJ, Scerri T, Marsh AP, Pope K, Gillies G, et al.
2015. 
Hemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR. Neurology
84:2029–32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4442098</ArticleId>
            <ArticleId IdType="pubmed">25878179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirzaa GM, Campbell CD, Solovieff N, Goold C, Jansen LA, et al.
2016. 
Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism. JAMA Neurol
73:836–45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4979321</ArticleId>
            <ArticleId IdType="pubmed">27159400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sim JC, Scerri T, Fanjul-Fernández M, Riseley JR, Gillies G, et al.
2016. 
Familiar cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3. Ann Neurol
79:132–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26285051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mirzaa GM, Conti V, Timms AE, Smyser CD, Ahmed S, et al.
2015. 
Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next generation sequencing study. Lancet Neurol
14:1182–95</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4672724</ArticleId>
            <ArticleId IdType="pubmed">26520804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terrone G, Voisin N, Abdullah Alfaiz A, Cappuccio G, et al.
2016. 
De novo PIK3R2 variant causes polymicrogyria, corpus callosum hyperplasia and focal cortical dysplasia. Eur J Hum Genet
24:1359–62</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4989218</ArticleId>
            <ArticleId IdType="pubmed">26860062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shick V, Majores M, Engels G, Spitoni S, et al.
2006. 
Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasia. Acta Neuropathol
112:715–25</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17013611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crino PB, Nathanson KL, Henske EP. 2006. 
The tuberous sclerosis complex. N Engl J Med
35:1345–56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17005952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim JS, Gopalappa R, Kim SH, Ramakrishna S, Lee M, et al.
2017. 
Somatic mutations in TSC1 and TSC2 cause focal cortical dysplasia. Am J Hum Genet
100:454–72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5339289</ArticleId>
            <ArticleId IdType="pubmed">28215400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martin KR, Zhou W, Bowman MJ, Shih J, Au KS, et al.
2017. 
The genomic landscape of tuberous sclerosis complex. Nat Commun
8:15816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5481739</ArticleId>
            <ArticleId IdType="pubmed">28643795</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
